A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 15, 2025

Primary Completion Date

July 19, 2026

Study Completion Date

July 19, 2026

Conditions
Ulcerative Colitis (UC)
Interventions
DRUG

Mesalamine

Oral Capsules

DRUG

Placebo

Oral Capsule

Trial Locations (10)

726

San Juan Bautista School of Medicine /ID# 243377, Caguas

912

Centro de Investigaciones Clinicas San Jorge Children's and Women's Hospital /ID# 244595, San Juan

20910

Virgo Carter Pediatrics /ID# 241556, Silver Spring

24014

Carilion Medical Center /ID# 244398, Roanoke

30315

Treken Primary Care /ID# 241302, Atlanta

44106

UH Cleveland Medical Center /ID# 243375, Cleveland

60621

Eagle Clinical Research /ID# 242045, Chicago

73104

Children's Hospital Oklahoma /ID# 242614, Oklahoma City

20010-2916

Childrens National /ID# 243379, Washington D.C.

32225-3131

Angel Kids Pediatrics /ID# 244874, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY